20
Participants
Start Date
June 30, 2021
Primary Completion Date
October 5, 2022
Study Completion Date
November 14, 2022
IXT-m200
IXT-m200 binds METH with high selectivity and affinity. The product contains a murine METH-binding variable region and the constant domains of a human immunoglobulin G (IgG) 2κ. This antibody isotype was chosen because of the lower risk of immune response compared to an IgG1 or IgG3. IXT-m200 targets METH, does not rely on binding to any endogenous target for its action, and has been well-tolerated in previous clinical studies.
Lorazepam
Lorazepam is a benzodiazepine that is safe and commonly used to treat agitation and dysphoria in the emergency setting.
Haloperidol
Haloperidol is commonly used to treat agitation due to psychosis.
University of Arkansas for Medical Sciences, Little Rock
University of New Mexico Hospital, Albuquerque
Providence Regional Medical Center Everett, Everett
Sacred Heart Medical Center, Spokane
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NIH
InterveXion Therapeutics, LLC
INDUSTRY